Drugs.com - Prescription Drug Information Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Bkemv (eculizumab-aeeb), an Interchangeable Biosimilar to Soliris

Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat...

CDC Reports Third Dairy Worker Infected With Bird Flu, Risk to Public Remains 'Low'

Amid an ongoing outbreak of bird flu in dairy cows, there's been a third case of H5N1 avian flu confirmed in a dairy worker, U.S. health officials reported...

Doctors Used See-Through Plastic 'Window' to Monitor Injured Man's Brain

California skateboarder Jared Hager has become the first person to receive a transparent skull replacement, which allows doctors to better view the function...

Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa

Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online...

Patient Characteristics Linked to Performance of AI Algorithm for DBT

For analyzing negative screening digital breast tomosynthesis (DBT) examinations, patient characteristics influence the case and risk scores of an artificial...

HTN, Albuminuria Risks No Worse for Kidney Donors Versus Nondonors

Living kidney donors and nondonors have similar risks for hypertension and albuminuria, according to a study published online May 23 in the Journal of...

Delay in Hospital Arrival After Stroke Linked to Social Vulnerability

Areas with a high incidence of delay in hospital arrival after ischemic stroke are characterized by increased social vulnerability, according to a study...

Study Confirms Effectiveness of 'Watch-and-Wait' Approach to Prostate Cancer

For a large percentage of men with prostate cancer, the tumor may be so slow-growing that doctors advise a "watch-and-wait" approach instead of active...

PTSD, Anxiety Is Rising Among College Students

America's college students seem to be more stressed than ever, with a new report finding a sharp rise in cases of post-traumatic stress disorder (PTSD)...

CG Pharmaceuticals Prepares to Showcase Its Ongoing Phase 2 Study for Ivaltinostat in Metastatic Pancreatic Ductal Adenocarcinoma

ORINDA, Calif., May 29, 2024. CG Pharmaceuticals, a company dedicated to advancing innovative therapies to improve the lives of patients with cancer, prepares...

Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome

MELBOURNE, Australia, May 27, 2024.  Neuren Pharmaceuticals (ASX: NEU) today announced top-line results from its Phase 2 clinical trial of NNZ-2591...

Subtle Mental Declines Occur Before Older Folk Quit Driving

One of the toughest decisions seniors face is when to give up their keys and stop driving. Even slight changes to the ability to remember, think and reason...

Read more news...

Recently Added

Recently added consumer and prescribing information: Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Bkemv Bkemv (eculizumab-aeeb) is a complement inhibitor interchangeable biosimilar to Soliris for the treatment of paroxysmal nocturnal...
  • Yesafili Yesafili (aflibercept-jbvf) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
  • Opuviz Opuviz (aflibercept-yszy) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development